NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery

Conditions:   Recurrent Head and Neck Squamous Cell Carcinoma;   Recurrent Hypopharyngeal Squamous Cell Carcinoma;   Recurrent Laryngeal Squamous Cell Carcinoma;   Recurrent Oral Cavity Squamous Cell Carcinoma;   Recurrent Oropharyngeal Squamous Cell Carcinoma;   Resectable Oropha ryngeal Squamous Cell Carcinoma Intervention:   Biological: Efineptakin alfa Sponsors:   Hyunseok Kang, MD;   NeoImmuneTech Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials